An in vitro evaluation of the native american ethnomedicinal plant Eryngium yuccifolium as a treatment for snakebite envenomation

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aim: At least seven North American tribes specifically mention the use of Eryngium (typically roots) as an anti-snake venom therapy. As snake envenomation is an endemic, life-threatening medical risk, is there a scientific basis for the Native American ethnomedicine? Could this be demonstrated in an assay amenable to mechanistic evaluation and high throughput screening for later isolation and possible evaluation as a source for a lead drug? Materials and Methods: Proteases, mainly metalloproteases, are thought to be the main pathological agents in most American snake venoms. Water extracts of four plant parts of Eryngium yuccifolium were tested for enzyme inhibition in three highly sensitive in vitro protease assays, with multiple venoms. Results: Interestingly, activity was found in all plant parts, not just the roots, in the general protease assay, also in the most specific assay for collagenases, but less so for elastases where enzymatic activity was low, and against five species of American snake venoms. Inhibition spared the activity of a mammalian elastase, suggesting it has some specificity. In dose response assays, inhibitory activity in extracts of Eryngium was noticeably more effective than randomly chosen plants and comparable to some others. Conclusions: All data shown here are consistent with pharmacological inhibition of proteases in at least selected venoms of common venomous snakes by Eryngium extracts. Moreover, as the genus is widely distributed in America, the ethnological practice of using this plant as an anti-snake venom treatment is supportable, may have been common, and suggests further bioactivity and phytochemical studies are warranted.

Original languageEnglish
Pages (from-to)219-225
Number of pages7
JournalJournal of Intercultural Ethnopharmacology
Volume5
Issue number3
DOIs
StatePublished - 1 Jan 2016

Fingerprint

Eryngium
Snake Bites
Snake Venoms
North American Indians
Assays
Peptide Hydrolases
Antivenins
Pancreatic Elastase
Venoms
Snakes
Plant Extracts
Phytochemicals
Metalloproteases
Traditional Medicine
Collagenases
Enzyme inhibition
Therapeutics
Population Groups
Bioactivity
Pharmacology

Keywords

  • Eryngium
  • Ethnopharmacology
  • Protease inhibition
  • Snakebite
  • Toxins
  • Venoms

Cite this

@article{2818f3224fa04277b56df7e34dd73a25,
title = "An in vitro evaluation of the native american ethnomedicinal plant Eryngium yuccifolium as a treatment for snakebite envenomation",
abstract = "Aim: At least seven North American tribes specifically mention the use of Eryngium (typically roots) as an anti-snake venom therapy. As snake envenomation is an endemic, life-threatening medical risk, is there a scientific basis for the Native American ethnomedicine? Could this be demonstrated in an assay amenable to mechanistic evaluation and high throughput screening for later isolation and possible evaluation as a source for a lead drug? Materials and Methods: Proteases, mainly metalloproteases, are thought to be the main pathological agents in most American snake venoms. Water extracts of four plant parts of Eryngium yuccifolium were tested for enzyme inhibition in three highly sensitive in vitro protease assays, with multiple venoms. Results: Interestingly, activity was found in all plant parts, not just the roots, in the general protease assay, also in the most specific assay for collagenases, but less so for elastases where enzymatic activity was low, and against five species of American snake venoms. Inhibition spared the activity of a mammalian elastase, suggesting it has some specificity. In dose response assays, inhibitory activity in extracts of Eryngium was noticeably more effective than randomly chosen plants and comparable to some others. Conclusions: All data shown here are consistent with pharmacological inhibition of proteases in at least selected venoms of common venomous snakes by Eryngium extracts. Moreover, as the genus is widely distributed in America, the ethnological practice of using this plant as an anti-snake venom treatment is supportable, may have been common, and suggests further bioactivity and phytochemical studies are warranted.",
keywords = "Eryngium, Ethnopharmacology, Protease inhibition, Snakebite, Toxins, Venoms",
author = "Price, {Joseph A.}",
year = "2016",
month = "1",
day = "1",
doi = "10.5455/jice.20160421070136",
language = "English",
volume = "5",
pages = "219--225",
journal = "Journal of Intercultural Ethnopharmacology",
issn = "2146-8397",
publisher = "Ejmanager LLC",
number = "3",

}

TY - JOUR

T1 - An in vitro evaluation of the native american ethnomedicinal plant Eryngium yuccifolium as a treatment for snakebite envenomation

AU - Price, Joseph A.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Aim: At least seven North American tribes specifically mention the use of Eryngium (typically roots) as an anti-snake venom therapy. As snake envenomation is an endemic, life-threatening medical risk, is there a scientific basis for the Native American ethnomedicine? Could this be demonstrated in an assay amenable to mechanistic evaluation and high throughput screening for later isolation and possible evaluation as a source for a lead drug? Materials and Methods: Proteases, mainly metalloproteases, are thought to be the main pathological agents in most American snake venoms. Water extracts of four plant parts of Eryngium yuccifolium were tested for enzyme inhibition in three highly sensitive in vitro protease assays, with multiple venoms. Results: Interestingly, activity was found in all plant parts, not just the roots, in the general protease assay, also in the most specific assay for collagenases, but less so for elastases where enzymatic activity was low, and against five species of American snake venoms. Inhibition spared the activity of a mammalian elastase, suggesting it has some specificity. In dose response assays, inhibitory activity in extracts of Eryngium was noticeably more effective than randomly chosen plants and comparable to some others. Conclusions: All data shown here are consistent with pharmacological inhibition of proteases in at least selected venoms of common venomous snakes by Eryngium extracts. Moreover, as the genus is widely distributed in America, the ethnological practice of using this plant as an anti-snake venom treatment is supportable, may have been common, and suggests further bioactivity and phytochemical studies are warranted.

AB - Aim: At least seven North American tribes specifically mention the use of Eryngium (typically roots) as an anti-snake venom therapy. As snake envenomation is an endemic, life-threatening medical risk, is there a scientific basis for the Native American ethnomedicine? Could this be demonstrated in an assay amenable to mechanistic evaluation and high throughput screening for later isolation and possible evaluation as a source for a lead drug? Materials and Methods: Proteases, mainly metalloproteases, are thought to be the main pathological agents in most American snake venoms. Water extracts of four plant parts of Eryngium yuccifolium were tested for enzyme inhibition in three highly sensitive in vitro protease assays, with multiple venoms. Results: Interestingly, activity was found in all plant parts, not just the roots, in the general protease assay, also in the most specific assay for collagenases, but less so for elastases where enzymatic activity was low, and against five species of American snake venoms. Inhibition spared the activity of a mammalian elastase, suggesting it has some specificity. In dose response assays, inhibitory activity in extracts of Eryngium was noticeably more effective than randomly chosen plants and comparable to some others. Conclusions: All data shown here are consistent with pharmacological inhibition of proteases in at least selected venoms of common venomous snakes by Eryngium extracts. Moreover, as the genus is widely distributed in America, the ethnological practice of using this plant as an anti-snake venom treatment is supportable, may have been common, and suggests further bioactivity and phytochemical studies are warranted.

KW - Eryngium

KW - Ethnopharmacology

KW - Protease inhibition

KW - Snakebite

KW - Toxins

KW - Venoms

UR - http://www.scopus.com/inward/record.url?scp=85014307788&partnerID=8YFLogxK

U2 - 10.5455/jice.20160421070136

DO - 10.5455/jice.20160421070136

M3 - Article

AN - SCOPUS:85014307788

VL - 5

SP - 219

EP - 225

JO - Journal of Intercultural Ethnopharmacology

JF - Journal of Intercultural Ethnopharmacology

SN - 2146-8397

IS - 3

ER -